SyzOnc

www.syzonc.com
2929 Arch St, Fl 4
Philadelphia, PA 19104

Company Info

Year Established
2023

Contacts

Karin Eisinger, Ph.D.
Co-Founder & CEO

Company Description

SyzOnc is developing tumor microenvironment modulators for cancer patients using a tech-enabled, systems-level approach.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.